ReviewNew insights into the formation and resolution of ultra-fine anaphase bridges
Highlights
► Human cells contain ultra-fine DNA bridges in anaphase (UFBs) that cannot be stained with dyes. ► DNA repair proteins, such as the Bloom's syndrome helicase, BLM, and a translocase, PICH, bind UFBs. ► Cells lacking BLM or PICH contain more UFBs and these cannot be resolved in anaphase. ► Most UFBs originate from specific loci; either centromeres or fragile sites. ► A DNA damage response is triggered in G1 phase when the preceding anaphase is defective.
Introduction
A human body contains more than 10 trillion cells. Remarkably, almost all of the cells inherit an identical set of chromosomes even after many rounds of cell division. In order to achieve such high fidelity in genomic maintenance, cells have developed elegant and carefully controlled DNA metabolic pathways to replicate, repair and segregate the genetic material. These pathways involve a large number of proteins that typically manipulate DNA structure in one way or another such as DNA polymerases, nucleases, topoisomerases and helicases. In this review, we will focus on a discussion of a particular family of DNA metabolising enzymes called the RecQ helicases. This is because defects of RecQ helicases cause severe genetic disorders in humans that are associated with an increase in genomic instability, and a predisposition to cancer and premature aging.
In humans, there are 5 members of RecQ helicase family: BLM, WRN, RecQ1, RecQ4 and RecQ5. Defects in BLM, WRN and RecQ4 are associated with genetic disorders; namely, Bloom's syndrome (BS), Werner's syndrome (WS) and Rothmund–Thomson syndrome (RTS), respectively. All of these disorders show signs of growth retardation, skin abnormalities and cancer predisposition, amongst other things. Patients with WS and RTS display premature aging, which is particularly striking in the case of WS, and are prone to the development of certain types of cancer, such as sarcomas and skin cancers. In contrast, BS patients are predisposed to all types of cancers that are found in general population. BS cells display an approximately 10-fold elevation in the frequency of sister-chromatids exchange (SCE), a marker for increased homologous recombination [1], [2], [3]. Therefore, BLM is of particular interest for studying the relationship between genomic instability and tumorigenesis.
RecQ helicases are highly conserved from bacteria to humans, primarily in the seven ‘signature’ helicase motifs (I, Ia, II–VI) [4]. In most cases, this domain is adjacent to a so-called RQC domain that interacts with DNA and contains a characteristic Zn2+ binding motif. RecQ helicases have Mg2+- and DNA-dependent ATPase activity, as well as 3′–5′ DNA helicase activity [5]. BLM and WRN, as well as their bacterial and budding yeast orthologues, RecQ and Sgs1, contain an additional conserved domain; the Helicase and RNaseD C-terminal (HRDC) domain, which has been shown also to be involved in DNA binding. In contrast, regions outside these domains are poorly conserved, and are thought to be involved in other functions such as mediating protein–protein interactions. A particularly conserved BLM binding partner is topoisomerase III (TopoIIIα in humans) [6], [7]. Recently, two additional partners, RMI1 and RMI2, were identified in humans, and studies showed that these partners have regulatory functions to facilitate the activities of BLM-TopoIIIα [8], [9], [10], [11], [12], [13]. Purified BLM, on its own, can unwind a variety of DNA structures that mimic replication and recombination intermediates. These include a partial duplex DNA with a 3′ tail, a forked structure, a D-loop structure and a 4-way/X-junction. It can also unwind non-B-form G-quadruplex (G4) DNA, a structure that is proposed to form in guanine-rich sequences such as telomeric and ribosomal DNA regions (Fig. 1A) [14]. Moreover, BLM can catalyze branch migration of a central intermediate in homologous recombination, the Holliday junction (HJ) (Fig. 1B) [2]. Very interestingly, acting in concert with TopoIII/RMI1, BLM and Sgs1 are capable of catalyzing a unique reaction, termed ‘double-HJ dissolution’ (Fig. 1C) which serves to complete homologous recombination reactions [2], [15], [16]. This reaction requires both HJ branch migration and ssDNA decatenation. Recently, two studies demonstrated that an additional function of Sgs1/TopoIII/Rmi1 is to facilitate 5′–3′ end resection of double stranded DNA catalyzed by the Dna2 nuclease [17], [18]. This reaction is proposed to initiate homologous recombination [19]. Overall, the findings indicate that the RecQ helicases play multiple roles in processing early and late DNA intermediates for replication and recombination. In this review, we will focus on another newly identified role of the BLM complex, which is to ensure faithful chromosome segregation. A detailed discussion of Bloom's syndrome and of BLM's biochemical properties can be found in other recent reviews [1], [2], [3].
Section snippets
The discovery of ultra-fine anaphase bridges
In unperturbed S phase cells, BLM, together with its binding partners, topoisomerase IIIα and RMI1/2, localizes to nuclear foci that represent PML nuclear bodies. Following genotoxic insult, these proteins re-localize to new foci that define sites of DNA damage [7], [8], [9], [20]. In general, these BLM foci disappear when cells enter mitosis. It is believed that the loss of nuclear foci on mitotic chromosomes is due to hyper-phosphorylation of BLM by mitotic kinases that induce dissociation of
UFBs originate from specific loci
It has been shown that the majority of UFBs originate from centromeres. The number of UFBs decreases with progression through anaphase–telophase, and they mostly disappear when cells progress to late telophase. It is still not formally proven that the disappearance of UFBs (detected by PICH or BLM staining) in telophase is due to DNA resolution/breakage rather than due to the degradation of PICH and BLM complex, as studies have shown that BLM is degraded after mitotic exit [21]. However, γH2AX,
Fanconi anemia proteins define a sub-set of UFBs
Is DNA catenation the only source of UFBs? The simple answer seems to be no. By screening for the presence of proteins involved in DNA replication and recombination on UFBs, the Fanconi anemia (FA) proteins, FANCD2 and FANCI were found to localize not to the bridge DNA, but to the termini of a subset of UFBs (hereafter named FA-associated UFBs to distinguish from the non-FA-associated UFBs) [38], [39]. Like BS, FA is a rare genetic disorder. FA patients are predisposed to cancer, especially
FANC-M is also found on UFBs
As mentioned above, a recent finding showed that FANC-M also displays localization to UFBs, but this is restricted to late anaphase/telophase cells. Interestingly, FANC-M was rarely shown to co-localize with BLM or PICH on UFBs, but the frequency of telophase cells having FANC-M-coated UFBs also increased after FANC-A or FANC-I depletion. A significant reduction in the frequency of FANC-M-coated, but not PICH-coated, UFBs was found in the absence of BLM [38], [48]. This suggests that the UFB
What happens to UFBs after mitosis?
One very important question is what is the fate(s) of UFBs after mitotic exit? Most, if not all, cells show non-FA (catenation)-associated UFBs at centromeres in early anaphase. These bridges gradually diminish in number with mitotic exit. Interestingly, DNA double stranded breaks (DSBs) are not detectable in telophase or G1 daughter cells, as revealed by γH2AX staining. This indicates that the non-FA-associated bridges are likely to be resolved properly, without DSB formation, rather than by
Concluding remarks
In summary, it is very surprising that DNA catenanes and replication or recombination intermediates persist even during anaphase where sister-chromatids are well separated. Moreover, the resulting DNA lesions also persist into the next S-phase. Therefore, this offers a new conceptual framework for considering the completion of DNA replication and repair. We suggest that it is not necessary for replication repair to be limited to a single cell cycle. Instead, cells likely fail to complete
Acknowledgements
We would like to thank our colleagues for helpful discussions. Work in the Hickson laboratory is supported by The Nordea Foundation, The Danish Cancer Society and the Association for International Cancer Research.
References (50)
- et al.
The Bloom's syndrome gene product is homologous to RecQ helicases
Cell
(1995) - et al.
The Bloom's syndrome gene product is a 3′–5′ DNA helicase
J Biol Chem
(1997) - et al.
The Bloom's syndrome gene product interacts with topoisomerase III
J Biol Chem
(2000) - et al.
The Bloom's syndrome helicase unwinds G4 DNA
J Biol Chem
(1998) - et al.
Dephosphorylation and subcellular compartment change of the mitotic Bloom's syndrome DNA helicase in response to ionizing radiation
J Biol Chem
(2002) - et al.
PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint
Cell
(2007) - et al.
Wapl controls the dynamic association of cohesin with chromatin
Cell
(2006) - et al.
Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents
Cell
(2010) - et al.
Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2
Cell
(2010) - et al.
Resolution of converging replication forks by RecQ and topoisomerase III
Mol Cell
(2008)
FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi Anemia
Mol Cell
53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks
Cell
DNA helicases in DNA repair
Annu Rev Genet
RecQ helicases: multifunctional genome caretakers
Nat Rev Cancer
RecQ helicases: multiple structures for multiple functions?
HFSP J
The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase
Mol Cell Biol
BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity
EMBO J
RMI, a new OB-fold complex essential for Bloom syndrome protein to maintain genome stability
Genes Dev
BLAP18/RMI2, a novel OB-fold-containing protein, is an essential component of the Bloom helicase-double Holliday junction dissolvasome
Genes Dev
RMI1/NCE4, a suppressor of genome instability, encodes a member of the RecQ helicase/Topo III complex
EMBO J
Yeast Rmi1/Nce4 controls genome stability as a subunit of the Sgs1–Top3 complex
Mol Cell Biol
BLAP75/RMI1 promotes the BLM-dependent dissolution of homologous recombination intermediates
Proc Natl Acad Sci USA
The Bloom's syndrome helicase suppresses crossing over during homologous recombination
Nature
Rmi1 stimulates decatenation of double Holliday junctions during dissolution by Sgs1-Top3
Nat Struct Mol Biol
DNA end resection by Dna2-Sgs1-RPA and its stimulation by Top3-Rmi1 and Mre11-Rad50-Xrs2
Nature
Cited by (85)
Emerging roles of DNA repair factors in the stability of centromeres
2024, Seminars in Cell and Developmental BiologyERCC6L2 mitigates replication stress and promotes centromere stability
2023, Cell ReportsHallmarks of DNA replication stress
2022, Molecular CellGenotoxic and antigenotoxic potential of herbal mixture and five medicinal plants used in ethnopharmacology
2019, South African Journal of BotanyCitation Excerpt :Stevens et al., 2011). Vagrant and lagging chromosomes (Fig. 1(11, 15)) are indicators of spindle poisoning (Rank and Nielsen, 1994; Redli et al., 2016), while chromatin bridges (Fig. 1(12b, 17)) arise as a consequence of fusion and failed segregation of sister chromatids' telomeres (Chan and Hickson, 2011). The fragmented, sticky, chained, vagrant and lagging chromosomes observed, as well as chromatin bridges in A. cepa meristematic cells, are usually of irreversible nature and indicate highly toxic properties of tested extracts (Fiskesjo, 1985).
The nuclear isoforms of the Fragile X mental retardation RNA-binding protein associate with genomic DNA bridges
2023, Molecular Biology of the CellRECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1
2022, Journal of Clinical Investigation